This impressive new 100,000ft2 state-of-the-art multi- product Good Manufacturing Practice (GMP) is part of Almac’s global investment plan and will be purpose-built for the site’s material handling, dispensing, blending, tablet compression and tablet coating.
This Centre of Excellence for manufacturing will house a custom-designed dispensary area, multiple production suites, process equipment wash facilities and a lineside warehouse for ambient, refrigerated and frozen storage. The new facility will primarily support solid oral dose products, complementing Almac’s existing capabilities in this area.
The facility, which will be operational from Q3 2024, will expand Almac Pharma Services’ existing manufacturing capabilities and offers additional capacity for further strategic production contracts. The high-specification production suites have been designed with flexibility and a wide range of uses in mind which offers opportunities for clients to install bespoke technology specific to their individual needs.
This CL3 environment is in constant production, requiring closely controlled traffic and personnel management systems. Due to the critical and potentially hazardous nature of the products, the ventilation systems are extensive and will operate under very tight limitations. Complex electrical infrastructure HV & LV, including support systems to maintain supply with UPS and backup generator as resilience to allow uninterrupted operation.
